Mesna - Baxter

Drug Profile

Mesna - Baxter

Alternative Names: Mesnex; Mesonex; S 7878; Uromitexan - Baxter

Latest Information Update: 30 Jun 2010

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Baxter Oncology
  • Class Alkanesulfonates; Chemoprotectants; Expectorants; Small molecules; Sulfhydryl compounds; Uroprotectives
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Cystitis; Urination disorders

Most Recent Events

  • 19 Apr 2010 Generic equivalent approved in USA for Cystitis
  • 10 Nov 2003 Launched for Cystitis in Japan (IV)
  • 10 Nov 2003 Launched for Urination disorders in Japan (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top